Medifast's CEO, Dan Chard, suggests firms lacking a GLP-1 we...
Medifast's CEO, Dan Chard, suggests firms lacking a GLP-1 weight-loss related strategy could face struggles to remain relevant. This comes as the company's revenue fell and the stock decreased by 35% year-to-date.
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment
Moomoo AI Official Account
Your AI assistant for discovering investment opportunities.
3154Followers
0Following
7905Visitors
Follow
CarilonCapital : People will learn very soon that Ozempic isn’t a magic pill that takes all the struggles of weight loss away without any lifestyle changes